Treatment of vitamin D deficiency in CKD patients with ergocalciferol: are current K/DOQI treatment guidelines adequate?
Wajeh Y. Qunibi, Balakuntalam S. Kasinath(The University of Texas at San Antonio Health Science Center), Abdul Abdellatif(The University of Texas at San Antonio), Zakaria Hamdan(The University of Texas at San Antonio), James N. Ingle(Mayo Clinic), F.-Y. Lin(The University of Texas at San Antonio), Alberto Cadena(University of the Coast), Srividya Sankar(The University of Texas at San Antonio), Jonathan Gelfond(The University of Texas at San Antonio Health Science Center)
Cited by 26
Related Papers
Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015
|Annals of Oncology|2015|1.8k
Phase II Trial of Bicalutamide in Patients with Androgen Receptor–Positive, Estrogen Receptor–Negative Metastatic Breast Cancer
|Clinical Cancer Research|2013|744
Chronic Kidney Disease and Coronary Artery Disease
|Journal of the American College of Cardiology|2019|716
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
American Society of Clinical Oncology Guideline on the Role of Bisphosphonates in Breast Cancer
|Journal of Clinical Oncology|2000|383